Lung Cancer | Oncology Today with Dr Neil Love: Key Presentations in Lung Cancer from the 2022 ASCO Annual Meeting (Companion Faculty Lecture)
Research To Practice | Oncology Videos · Dr. Neil Love
August 24, 20221h 0m
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring a slide presentation and related discussion from Dr Joshua Sabari, including the following topics:
- Recent updates from ASCO 2022 in the use of EGFR- and MET-targeted therapies (0:00)
- Targeting HER3 in patients with advanced non-small cell lung cancer (NSCLC) with and without EGFR mutations (16:04)
- Recent updates in therapy for patients with EGFR exon 20 insertion mutations (21:47)
- DESTINY-Lung04 trial: Trastuzumab deruxtecan for patients with HER2 exon 19 or 20 mutations (2921)
- Using mutational status in predicting patient benefit from chemoimmunotherapy (34:51)
- Immune checkpoint inhibition for patients with NSCLC with EGFR mutations (38:41)
- Combining novel agents with immune checkpoint inhibitors for patients with NSCLC and high PD-L1 expression (47:36)